Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections

Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections

Objective: To assess the effect of a pharmacist-driven, polymerase chain reaction (PCR)−based nasal screening protocol for methicillin-resistant Staphylococcus aureus (MRSA) on vancomycin therapy duration and on rates of adverse drug events and 30-day hospital readmission. Patients and Methods: From...

Full description

Bibliographic Details
Main Authors: Nathan L. Woolever, PharmD, RPh, Rachel J. Schomberg, PharmD, RPh, Songlin Cai, PharmD, RPh, Ross A. Dierkhising, MS, Ala S. Dababneh, MD, Richard C. Kujak, PharmD, RPh
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454820300941

Similar Items

Similar Items